IRIS
BOCCARELLI, Angelina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.760
EU - Europa 2.421
AS - Asia 2.318
SA - Sud America 696
Continente sconosciuto - Info sul continente non disponibili 417
AF - Africa 151
OC - Oceania 4
AN - Antartide 1
Totale 11.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.572
RU - Federazione Russa 883
SG - Singapore 881
CN - Cina 629
IT - Italia 565
BR - Brasile 546
SE - Svezia 292
HK - Hong Kong 232
VN - Vietnam 165
DE - Germania 147
UA - Ucraina 118
FI - Finlandia 116
FR - Francia 105
CI - Costa d'Avorio 88
GB - Regno Unito 77
IN - India 75
CA - Canada 74
BD - Bangladesh 69
AR - Argentina 54
ID - Indonesia 49
MX - Messico 30
IQ - Iraq 28
EC - Ecuador 27
JP - Giappone 25
TR - Turchia 21
CO - Colombia 20
ZA - Sudafrica 20
ES - Italia 19
PK - Pakistan 18
NI - Nicaragua 17
BE - Belgio 16
SA - Arabia Saudita 16
PH - Filippine 15
VE - Venezuela 15
IE - Irlanda 14
NL - Olanda 14
CR - Costa Rica 13
PL - Polonia 13
UZ - Uzbekistan 13
JO - Giordania 12
PE - Perù 12
CL - Cile 9
SV - El Salvador 9
TN - Tunisia 9
GP - Guadalupe 8
IL - Israele 8
KE - Kenya 8
PY - Paraguay 7
AT - Austria 6
CW - ???statistics.table.value.countryCode.CW??? 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
KR - Corea 6
MY - Malesia 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
IR - Iran 5
KZ - Kazakistan 5
PR - Porto Rico 5
SC - Seychelles 5
AL - Albania 4
AU - Australia 4
DO - Repubblica Dominicana 4
EG - Egitto 4
GT - Guatemala 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
GE - Georgia 3
HN - Honduras 3
LB - Libano 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
SI - Slovenia 2
AM - Armenia 1
AQ - Antartide 1
BG - Bulgaria 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
CG - Congo 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
Totale 11.347
Salva come PNG Salva come JPEG
Città #
Ashburn 612
Singapore 426
Fairfield 400
San Jose 387
Woodbridge 377
Chandler 370
Jacksonville 262
Nyköping 242
Hong Kong 230
Houston 214
Milan 201
Seattle 193
Cambridge 171
Ann Arbor 164
Wilmington 158
Beijing 150
Council Bluffs 145
Bari 131
New York 103
Nanjing 101
Abidjan 88
Lawrence 88
Roxbury 88
Lauterbourg 82
Los Angeles 69
Boardman 67
Ho Chi Minh City 67
Dallas 60
Des Moines 60
Helsinki 53
Rome 51
Santa Clara 50
São Paulo 43
Princeton 39
Brooklyn 38
Columbus 36
Washington 32
Inglewood 31
Buffalo 30
Hanoi 28
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 25
Tokyo 25
San Diego 23
Munich 21
Chicago 19
Jakarta 19
Jiaxing 19
Pune 18
Belo Horizonte 17
Managua 17
Phoenix 17
Montreal 16
North Bergen 16
San Francisco 16
Brussels 15
The Dalles 15
Tianjin 15
Baghdad 14
Brasília 14
Moscow 14
Rio de Janeiro 14
Atlanta 13
Boston 13
Dublin 13
Guangzhou 13
Orem 13
Shanghai 13
Amman 12
Falkenstein 12
Curitiba 11
San José 11
Tashkent 11
Dhaka 10
Porto Alegre 10
Quito 10
Amsterdam 9
Changsha 9
Denver 9
London 9
Salvador 9
Toronto 9
Turin 9
Vancouver 9
Figino 8
Guayaquil 8
Johannesburg 8
Lima 8
Nairobi 8
Naples 8
Nuremberg 8
Paris 8
Riyadh 8
San Salvador 8
Warsaw 8
Bologna 7
Cape Town 7
Chennai 7
Totale 6.928
Salva come PNG Salva come JPEG
Nome #
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 731
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 273
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 262
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 195
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 190
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 190
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 187
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 183
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 174
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 170
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 164
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 162
Endothelial cells in the bone marrow of patients with multiple myeloma 142
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 141
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 140
Antitumour platinum iminoether complexes 139
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 136
Antitumour platinum-iminoether complexes 132
Platinum(II) based anticancer agents with a trans geometry 131
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 130
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 129
Antitumour ruthenium(II)-dimethylsulfoxide complexes 129
Antitumour platinum iminoether complexes 128
Antitumor activity of trans platinum complexes 126
A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics 124
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 124
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 123
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 120
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 120
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 116
A second life for MAO inhibitors? From CNS diseases to anticancer therapy 115
Chemical and Biological Evaluation of Novel 1H-Chromeno[3,2-c]pyridine Derivatives as MAO Inhibitors Endowed with Potential Anticancer Activity 113
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 111
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 111
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 109
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 106
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 106
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 105
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 105
null 104
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 103
Inhibition of matrix metallo proteinases activity by platinum complexes 102
A trans-platinum complex showing higher antitumor activity than the cis congeners 102
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 102
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 101
Bone Marrow Fibroblasts and Multiple Myeloma Progression 100
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 100
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 100
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 99
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 97
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 96
Complessi antitumorali di platino a geometria trans 96
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 95
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 94
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 92
null 92
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 90
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 90
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 89
null 88
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 88
Screening tests for selecting anticancer metal compounds 87
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 86
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 86
Platinum(II) complexes with acyclovir: synthesis and biological activity 84
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 84
Complessi antitumorali di platino a geometria trans 84
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 83
DNA interaction properties of platinum –iminoether complexes 83
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 83
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 82
Complessi antimetastatici di rutenio 80
A new generation of platinum anticancer complexes with trans geometry 80
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 78
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 76
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 75
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 74
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 74
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 73
Interazione DNA-isomeri del [PtCl2(DACH)] 69
null 68
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 67
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 67
null 67
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 67
null 66
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 66
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 65
null 65
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 65
null 65
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 64
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 63
Replacement of a NH3 by an iminoether in transplatin makes an antitumor drug from an inactive compound 62
Synthesis, Biophysical Studies, and Antiproliferative Activity of Platinum(II) Complexes Having 1,2-Bis(aminomethyl)carbobicyclic Ligands 60
New platinum antitumor complexes with chiral diamines 59
Zoledronic acid affects over-angiogenic phenotype of endothelial cells in patients with multiple myeloma 59
Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis 58
In vitro antitumour activity and cellular pharmacological properties of the platinum-iminoether complex trans-[PtCl2{E-HN=C(OMe)Me}2] 57
null 55
Totale 11.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.585
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022437 0 0 0 0 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024430 30 50 19 18 60 135 4 33 11 10 2 58
2024/20251.540 89 26 129 52 59 113 232 103 52 65 243 377
2025/20264.130 440 148 295 438 421 189 316 86 1.061 305 84 347
2026/20271.052 111 203 313 405 20 0 0 0 0 0 0 0
Totale 11.768